Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 29, 2010
Reporting Period: Three months ended March 31, 2010
The filing serves as a notification that the Company issued a press release on April 29, 2010, announcing financial results for the quarter ended March 31, 2010. The detailed results are contained in Exhibit 99.1, which is incorporated by reference.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the referenced press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only confirms the issuance of results for the three months ended March 31, 2010.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release containing the results but does not include the text of the commentary, guidance, or outlook.
Risks and Contingencies: No specific risks or contingencies are detailed in this document. The filing includes a standard disclaimer stating that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual revenue, net income, and cash flow figures for the quarter ended March 31, 2010.
- Verify year-over-year comparisons and management's discussion of financial performance in the referenced press release.
- Check for any forward-looking statements or guidance provided in the press release that are not present in this 8-K summary.
- Confirm the status of the Company's liquidity and debt obligations as detailed in the full financial report.